ID   SU223T-4
AC   CVCL_RK88
DR   SKIP; SKIP001711
DR   Wikidata; Q54970764
RX   PubMed=28089908;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK83 ! SU223-A2
OI   CVCL_RK84 ! SU223-A4
OI   CVCL_RK85 ! SU223-A7
OI   CVCL_RK86 ! SU223-B3
OI   CVCL_RK87 ! SU223-B5
OI   CVCL_RK89 ! SU223T-5
OI   CVCL_RK90 ! SU223T-6
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
RX   PubMed=28089908; DOI=10.1016/j.stem.2016.11.018; PMCID=PMC5508733;
RA   Chao M.P., Gentles A.J., Chatterjee S., Lan F., Reinisch A.,
RA   Corces M.R., Xavy S., Shen J.-F., Haag D., Chanda S., Sinha R.,
RA   Morganti R.M., Nishimura T., Ameen M., Wu H.-D., Wernig M., Wu J.C.,
RA   Majeti R.;
RT   "Human AML-iPSCs reacquire leukemic properties after differentiation
RT   and model clonal variation of disease.";
RL   Cell Stem Cell 20:329-344.e7(2017).
//